Form 13G Odyssey Therapeutics For: 18 May

Odyssey Therapeutics, a biotech firm, has filed a Form 13G with the SEC, revealing a significant stake in the company. The filing indicates a substantial increase in ownership by a single entity, but the exact percentage and identity of the investor remain undisclosed. The filing was submitted on May 18.